Large Cap High Growth Potential

Results

267

13 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

267 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	GH	US$157.21	-6.7%	167.0%	US$21.1b	US$194.29	17.8	64.0%	n/a	Healthcare
	MDGL	US$507.56	-0.5%	37.2%	US$11.7b	US$678.06	9.1	63.7%	n/a	Pharmaceuticals & Biotech
	LITE	US$926.14	4.0%	699.4%	US$82.1b	US$1,148.30	27.2	104.4%	n/a	Tech
	NVDA	US$225.16	0.5%	24.8%	US$5.5t	US$302.83	34.2	22.9%	0.4%	Semiconductors
	AXSM	US$213.67	0.4%	95.6%	US$11.2b	US$285.42	14.4	61.1%	n/a	Pharmaceuticals & Biotech
	MOD	US$209.50	7.1%	51.0%	US$11.1b	US$310.29	77.2	51.3%	n/a	Capital Goods
	CRDO	US$259.90	4.0%	122.6%	US$48.5b	US$279.29	102.6	27.7%	n/a	Semiconductors
	BE	US$229.94	4.8%	407.8%	US$67.7b	US$275.08	276.5	42.5%	n/a	Capital Goods
	ARM	US$279.44	-1.1%	101.2%	US$298.5b	US$287.79	285.9	38.1%	n/a	Semiconductors
	MRVL	US$222.02	1.5%	191.4%	US$194.4b	US$257.29	77.0	26.4%	0.1%	Semiconductors
	AMD	US$514.39	6.4%	189.8%	US$839.7b	US$612.84	129.8	38.2%	n/a	Semiconductors
	SMTC	US$140.35	0.7%	181.7%	US$13.1b	US$205.25	12.0	71.9%	n/a	Semiconductors
	LSCC	US$130.46	0.3%	105.4%	US$18.5b	US$164.92	510.1	69.9%	n/a	Semiconductors
	ALAB	US$321.61	-3.8%	73.0%	US$55.8b	US$391.77	151.0	33.2%	n/a	Semiconductors
	RDDT	US$178.09	10.1%	-27.8%	US$34.3b	US$215.31	39.3	24.1%	n/a	Media
	AXON	US$612.83	7.3%	-18.7%	US$49.8b	US$693.40	249.8	28.5%	n/a	Capital Goods
	INSM	US$123.74	-5.6%	-3.2%	US$27.0b	US$200.05	23.8	66.9%	n/a	Pharmaceuticals & Biotech
	MTSI	US$316.44	1.8%	157.1%	US$24.2b	US$399.64	100.3	35.9%	n/a	Semiconductors
	FN	US$570.22	1.4%	72.9%	US$20.4b	US$732.44	48.5	22.3%	n/a	Tech
	ONTO	US$331.71	7.6%	210.2%	US$16.3b	US$387.30	122.8	51.2%	n/a	Semiconductors
	COHR	US$325.83	-14.1%	248.9%	US$63.8b	US$410.76	82.9	41.8%	n/a	Tech
	AVGO	US$392.99	-8.1%	28.3%	US$1.9t	US$527.88	63.8	33.7%	0.7%	Semiconductors
	APP	US$315.44	-9.0%	-28.1%	US$105.6b	US$548.52	23.9	20.6%	n/a	Media
	PRAX	US$366.81	1.7%	679.1%	US$10.2b	US$623.68	7.6	71.6%	n/a	Pharmaceuticals & Biotech

Page 1 of 8